Other studies have revealed that pioglitazone reduces intracellular Aβ in the CA1 region, decreases soluble Aβ and downregulates Apoe and Apba2 expression, involved in lipid shuttling and Aß processing, in 3xTg-AD mice [116]. This evidence concerns the gene APOE and Alzheimer disease.